Ruben A. Mesa, MD, FACP, weighs between the treatment options available for a patient with polycythemia vera, remarking on his considerations for using based on the benefits and limitations of each therapy in appropriate patients.

For more resources and information regarding anticancer targeted therapies: [ Ссылка ]

свернуть